Phase 3 Pivotal Cardigan II study exceeds 50% enrollment- - -Topline results for Phase 3 Pivotal Cardigan I and Cardigan...
Responsible for managing clinical development and the regulatory processes for ATI-2173, an ASPIN, which is in development as part of...
OCALA, Fla., April 27, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) today announced that it has completed...
Enhanced Infusion System (EIS) Patented IV add-in infusion system reduces the risk of infection and embolism, saves time and money....
SALT LAKE CITY, April 27, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and...
– Proceeds to support clinical progress of differentiated anti-CD47 candidate AO-176 for patients with solid tumors and hematologic malignancies – –...
DALLAS, April 27, 2021 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) (Nasdaq: TIL) received orphan drug designation (ODD) from the...
SOMERVILLE, Mass., April 27, 2021 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch” or “Finch Therapeutics”) (Nasdaq: FNCH), a clinical-stage...
MOUNTAIN VIEW, Calif., April 27, 2021 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on...
Henry Rath announced as chief business officer, Alison O’Neill as chief medical officer and Jessica Fees as chief financial officerCAMBRIDGE,...
TORONTO, April 27, 2021 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (CSE: PHRM) (OTCQB: PHRRF), a specialty...
Addresses High Unmet Medical Need for Women with Advanced Ovarian Cancer U.S. FDA Granted Fast Track Designation in 2018 Trial...
Axsome to host conference call and webcast on Monday, May 10, 2021 at 8:00 AM Eastern Time NEW YORK, April...
Company expects to close the Cantel Medical acquisition by June 2, 2021, pending shareholder voteDUBLIN, IRELAND, April 27, 2021 (GLOBE...
WIXOM, Mich., April 27, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the...
Development of Krysalis(TM) Therapeutic Pod to Deliver Headset-free Virtual Experience with Biometric MonitoringVancouver, British Columbia--(Newsfile Corp. - April 27, 2021)...
DEFINING CLEAR DEVELOPMENT PATHWAY FOR NEXT GENERATION OF PSYCHEDELIC MEDICINES TO TREAT ADDICTIONToronto, Ontario--(Newsfile Corp. - April 27, 2021) -...
Managed interoperability with pre-built connectivity to Lyniate Rhapsody and Lyniate Corepoint BOSTON--(BUSINESS WIRE)--Lyniate, the most trusted connector of healthcare worldwide,...
Establishment Labs Also Announces CE Mark Filing of Tools for Motiva Mia System SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc....
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the...